SCHEMBL3044668

SCHEMBL3044668

Nc1c(-c2ccccc2)cc(-c2ccccc2)c2c1C(=O)NC2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 12/20 0.46
CHEK1 O14757 10/20 0.46
MEN1 O00255 1/20 0.46
PRKD3 O94806 1/20 0.46
PRKCG P05129 1/20 0.46
PRKCB P05771 1/20 0.46
CDK4 P11802 1/20 0.46
PRKCA P17252 1/20 0.46
PRKCH P24723 1/20 0.46
PRKCI P41743 1/20 0.46
PRKCE Q02156 1/20 0.46
KMT2A Q03164 1/20 0.46
PRKCQ Q04759 1/20 0.46
PRKCZ Q05513 1/20 0.46
PRKCD Q05655 1/20 0.46
PRKD1 Q15139 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TNIK Q9UKE5 1/20 0.46
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3046283 0.85 MAPT (0.40) WEE1CHEK1MEN1PRKD3PRKCG
SCHEMBL3048914 0.80 WEE1 (0.51) WEE1CHEK1MEN1PRKD3PRKCG
SCHEMBL18170525 0.78 MAOA (0.45) WEE1CHEK1MEN1PRKD3PRKCG
SCHEMBL21278695 0.77 HSD17B10 (0.44) MEN1KMT2ATDP1PDE4APDE4B
Hydrochloric Acid SCHEMBL28480643 0.75 HSD17B10 (0.43) MEN1KMT2ATDP1PDE4APDE4B
SCHEMBL7767469 0.74 MEN1 (0.50) WEE1CHEK1MEN1PRKD3PRKCG
SCHEMBL7806624 0.73 PARP1 (0.47) WEE1CHEK1MEN1KMT2ATDP1
SCHEMBL30594444 0.72 HSD17B10 (0.44) MEN1KMT2ATDP1PDE4APDE4B
SCHEMBL21046679 0.72 HSD17B10 (0.44) MEN1KMT2ATDP1PDE4APDE4B
SCHEMBL866304 0.72 HSD17B10 (0.40) MEN1KMT2ATDP1PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
EP-2108642-A1 JAK INHIBITOR Kyowa Hakko Kirin Co., Ltd. (JP) 2009-10-14 EP disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 WEE1 965/4885CHEK1 3306/4885MEN1 1165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.